Title: Mobilize AMERICA Act
Policy area: Health

Summary:
Mobilize America to Manufacture Equipment Required for Independence from Communist Adversaries Act or the Mobilize AMERICA Act
This bill requires the Department of Health and Human Services to award grants to manufacturers of pharmaceuticals and other medical supplies to ensure domestic availability of critical materials to respond to pandemics or other public health emergencies.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 4952 Introduced in Senate (IS)]

<DOC>






116th CONGRESS
  2d Session
                                S. 4952

   To establish a grant program to expand the domestic production of 
                       certain medical supplies.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            December 2, 2020

   Ms. Ernst introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
   To establish a grant program to expand the domestic production of 
                       certain medical supplies.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Mobilize America to Manufacture 
Equipment Required for Independence from Communist Adversaries Act'' or 
the ``Mobilize AMERICA Act''.

SEC. 2. EXPANDING THE DOMESTIC PRODUCTION OF MEDICAL SUPPLIES.

    Title III of the Public Health Service Act is amended by inserting 
after section 319F-4 (42 U.S.C. 247d-6e) the following:

``SEC. 319F-5. EXPANDING THE DOMESTIC PRODUCTION OF MEDICAL SUPPLIES.

    ``(a) In General.--The Secretary, in consultation with the 
Secretary of Defense, shall award grants to drug, biological product 
(including vaccines), device (including respiratory protective 
devices), and other medical supply manufacturers for the purpose of 
incentivizing such manufacturers to manufacture such products 
domestically using advanced manufacturing, and to ensure that the 
Nation is able to retain or acquire necessary supplies to address 
critical public health needs, including countermeasures required during 
a pandemic or other public health emergency.
    ``(b) Eligible Products.--The Secretary, in consultation with the 
Secretary of Defense, shall compile and update a list of drugs, 
biological products (including vaccines), devices (including 
respiratory protective devices), and other medical supplies that are, 
or may become, critical supplies in the event of a pandemic or public 
health emergency.
    ``(c) Eligibility.--To be eligible for a grant under this section, 
a manufacturer shall submit an application to the Secretary at such 
time, in such manner, and containing such information as the Secretary 
may require, including the applicant's plan for the advanced 
manufacturing, domestically, of a product on the list under subsection 
(b).
    ``(d) Grant Awards.--A grant awarded under this section--
            ``(1) shall be used for the capital costs associated with 
        the installation of countermeasure manufacturing equipment 
        (including both final finished products and the related 
        critical components required for these products), including the 
        building and assembly of manufacturing equipment, modifications 
        to existing facilities to accommodate such equipment, or 
        expansion of existing facilities to accommodate such equipment, 
        in accordance with the advanced manufacturing plan set forth in 
        the application under subsection (c); and
            ``(2) shall be in amount not to exceed the amount 
        sufficient to cover up to 50 percent of the costs described in 
        paragraph (1).
    ``(e) Waiver of Certain Requirements.--The requirements of section 
75.323 of title 45, Code of Federal Regulations (or any successor 
regulations) shall not apply with respect to a grant awarded under this 
section.
    ``(f) Ongoing Monitoring.--The Secretary, in coordination with the 
Secretary of Defense, shall establish and implement procedures for the 
ongoing monitoring of the program under this section to ensure that 
such program works toward the goal of expanding domestic production of 
drugs, biological products (including vaccines), devices (including 
respiratory protective devices), and other medical supplies.
    ``(g) Reporting.--Not later than 180 days after the date of the 
enactment of the Mobilize America to Manufacture Equipment Required for 
Independence from Communist Adversaries Act and annually thereafter, 
the Secretary, in coordination with the Secretary of Defense, shall 
submit to Congress a report on the program under this section. Each 
such report shall include certification that all funds appropriated for 
the purpose of carrying out this section are used solely for such 
purpose.
    ``(h) Authorization of Appropriations.--To carry out this section, 
there are authorized to be appropriated $250,000,000 for each of fiscal 
years 2021 through 2025.''.
                                 <all>